CCES 2015 CCES vs Athlete

In August 2015 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the minor Athlete after his sample tested positive for the prohibited substance Salbutamol in a concentration above the WADA threshold.

After notification the Athlete admitted the violation, waived his right to be heard and accepted the sanction proposed by the CCES.

The CCES established that the Athlete was not at significant fault or negligence for the violation. When tested the Athlete was not a National or International athlete as defined under the Rules and at all times he used the medication Salbutamol as prescribed by his physician.

Therefore the CCES decides on 10 December 2015 to impose a reprimand on the minor Athlete without a period of ineligibility.

Original document

Parameters

Legal Source
National Decisions
Date
10 December 2015
Original Source
Canadian Centre for Ethics in Sport (CCES)
Country
Canada
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Minor
No intention to enhance performance
No Significant Fault or Negligence
Reprimand / warning
Waiver of "right to be heard"
Sport/IFs
American Football (IFAF) - International Federation of American Football
Other organisations
Canadian Centre for Ethics in Sport (CCES)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
21 June 2017
Date of last modification
12 April 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin